Japan Hypertension Society Amends Treatment Guidelines
This article was originally published in PharmAsia News
Executive Summary
The Japanese Society of Hypertension revised its hypertension treatment guidelines, removing beta blockers as the first drug of choice and dividing them into the four classes of Ca-antagonists, ARBs, ACE inhibitors, and diuretics. Beta blockers will still be considered one major class of hypertensive drug particularly in cases of high blood pressure associated with heart disease.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.